Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Manufacturing & R&D Floor Area — United States by Year
Manufacturing & R&D Floor Area — United States (K sq ft)
Teva Pharmaceutical Industries Manufacturing & R&D Floor Area — United States: 1,891.0K sq ft in FY2025, down 43.4% from a year earlier.
Where the FY2025 figure comes from
“|| United States | 10 | 1,891”
Source: Form 10-K (0001193125-26-034532) ↗
Reported in SEC Form 10-K (Item 2. Properties).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Manufacturing & R&D Floor Area — United States (K sq ft) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,891.0 | -43.4% | Form 10-K (0001193125-26-034532) ↗ |
| FY2024 | Dec 31, 2024 | 3,340.0 | – | Form 10-K (0001193125-25-020826) ↗ |
| FY2017 | Dec 31, 2017 | 2,758.0 | – | Form 10-K (0001193125-18-039076) ↗ |
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Manufacturing & R&D Floor Area — United States (K sq ft), annual FY2017–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fac-us-sqft
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?